PMID: 22583430May 16, 2012Paper

A brief overview of tyrosine hydroxylase and α-synuclein in the Parkinsonian brain

CNS & Neurological Disorders Drug Targets
Wajihullah KhanQamre Alam

Abstract

Parkinson's disease (PD) is associated with neurodegeneration of the nigrostriatal tract and is accompanied with loss of tyrosine hydroxylase (TH) and dopamine (DA). Development of neuroprotective strategies targeting PD is often undermined by lack of proper understanding of processes contributing to the pathology. In this mini review we have tried to briefly outline the involvement of TH and α-synuclein in PD. Aberrant expression of α-synuclein is toxic to dopaminergic neurons. It interacts with ubiquitin-proteasomal processing system, implicated in oxidative injury and mitochondrial dysfunction which ultimately induce neurodegenration and cell death. The contributions of DJ-1 in TH regulation have also been discussed. Brain specific TH expression with the combined use of the pegylated immunoliposome (PILs) gene transfer technology and brain specific promoters as a new approach to treat PD has also been included.

Citations

Feb 5, 2019·Journal of Neurochemistry·Peter R Dunkley, Phillip W Dickson
Nov 2, 2017·Neural Regeneration Research·Barbara Pavan, Alessandro Dalpiaz
Dec 28, 2015·Tissue Engineering and Regenerative Medicine·Jun-Won YunByeong-Cheol Kang
Oct 30, 2018·Neurochemical Research·Thaiany Quevedo MeloMerari F R Ferrari
Apr 29, 2021·Dementia & Neuropsychologia·Caroline Cristiano RealLuiz Roberto de Britto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.